Floatz logo

Entecavir

Lactic Acidosis

Asan Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Lactic Acidosis cohort.

Asset / SponsorPhaseRating
Thiamine
The Cleveland Clinic
Phase 4BBB
LACTO-FLAVIN
Queen's University
Phase 4BB
L-Carnitine
Queen's University
Phase 4BB
Sodium Dichloroacetate
University of Florida
Phase 3BB
Lamivudine
Asan Medical Center
Phase 4BB
Sodium Lactate
Radboud University Medical Center
Early Phase 1CC

Same molecule, other indications

Entecavir is also rated in:

chronic hepatitis B virus infectionDormant
BBB
Indicative ·
74 / 100
View asset →
hepatitis B virus infectionDormant
BBB
Indicative ·
73 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →